Mike Frick

Biographic Data

ID6678800
NAMEMike Frick
GIVEN NAMESMike
FAMILY NAMEFrick
SIGNATUREFRICK M
AFFILIATIONSTreatment Action Group
ORCID0000-0002-3316-1930
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS3
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2026
H-INDEX1

  • TB vaccine development

    Open AccessMaría Florencia Pignataro, Carolinne Thays Scopel et al.ARTICLEFrontiers in Public Health2026

    Introduction: Every year, an estimated 10 million new cases of tuberculosis (TB) are diagnosed, and 1.6 million deaths occur worldwide due to this disease. The lack of new health technologies has affected the response to the global epidemic and control of this disease. The global TB vaccine pipeline has 17 candidates in clinical trials. Stakeholders are actively beginning readiness activities to prepare, introduce and deliver new TB vaccines that…

  • Fighting tuberculosis hand in hand

    Open AccessNandini Venkatesan, Lena Faust et al.ARTICLEPLOS Global Public Health2025

    Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…

  • Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach

    Open AccessMichelle M Gill, Rupali J Limaye et al.ARTICLEPLOS Global Public Health2025

    The promise of new tuberculosis (TB) vaccine candidates prompts the need for research on vaccine demand and health system readiness to help ensure effective and equitable vaccine deployment. We developed an approach to prioritizing countries for TB vaccine readiness research by combining stakeholder preferences, elicited through best-worst scaling (BWS) with an analytical hierarchy process (AHP) framework. We conducted a self-administered electro…

  • Right to science principles should guide global governance on health

    Open AccessGisa Dang, Mike FrickARTICLEFrontiers in Sociology2023References: 1

    OPINION article Front. Sociol., 21 November 2023Sec. Sociology of Law Volume 8 - 2023 | https://doi.org/10.3389/fsoc.2023.1271063

  • The Right to Science

    Open AccessLea Bishop, Mikel Mancisidor et al.BOOKThe Right to Science2021

    That everyone has a human right to enjoy the benefits of the progress of science and its applications comes as a surprise to many. Nevertheless, this right is pertinent to numerous issues at the intersection of science and society: open access; 'dual use' science; access to ownership and dissemination of data, knowledge, methods and the affordances and applications thereof; as well as the role of international co-operation, human dignity and othe…

  • Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials

    Open AccessKathleen M Macqueen, Natalie T Eley et al.ARTICLEJournal of Empirical Research on…2016Cited by: 2References: 3

    Good Participatory Practice Guidelines for TB Drug Trials (GPP-TB) were issued in 2012, based on similar guidelines for HIV prevention and reflecting growing acceptance of the importance of community engagement and participatory strategies in clinical research. Though the need for such strategies is clear, evaluation of the benefits and burdens are needed. Working with a diverse group of global TB stakeholders including advocates, scientists, and…

  • Tobacco retail clustering around schools in New York City

    Open AccessMike Frick, Márcia C CastroARTICLEHealth & Place2012Cited by: 1References: 5